Herein, we demonstrate indisulam as an effective anti-cancer agent in inhibiting tumor growth, decreasing HNSCC cell viability, and activating interferon alpha and interferon gamma pathways in HPV+ HNSCC. This evidence concerns the gene IFNG and head and neck squamous cell carcinoma.